Patents by Inventor Michael Fangching HUANG

Michael Fangching HUANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for the treatment of abnormal involuntary movement disorders
    Patent number: 11648244
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: May 16, 2023
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: David Stamler, Michael Fangching Huang
  • Methods for the treatment of abnormal involuntary movement disorders
    Patent number: 11564917
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: January 31, 2023
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: David Stamler, Michael Fangching Huang
  • Methods for the treatment of abnormal involuntary movement disorders
    Patent number: 11446291
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: September 20, 2022
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: David Stamler, Michael Fangching Huang
  • Methods for the Treatment of Abnormal Involuntary Movement Disorders
    Publication number: 20210275517
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Application
    Filed: March 25, 2021
    Publication date: September 9, 2021
    Inventors: David Stamler, Michael Fangching Huang
  • Methods for the treatment of abnormal involuntary movement disorders
    Patent number: 10959996
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Grant
    Filed: July 19, 2018
    Date of Patent: March 30, 2021
    Assignee: AUSPEX PHARMACEUTICALS, INC.
    Inventors: David Stamler, Michael Fangching Huang
  • METHOD FOR TREATING INTESTINAL DISEASES PRESENTING AT LEAST ONE INFLAMMATORY COMPONENT
    Publication number: 20200163888
    Abstract: The present disclosure relates to methods for treating intestinal diseases presenting at least one inflammatory component such as inflammatory bowel disease or diverticular disease and/or maintaining remission of intestinal diseases presenting at least one inflammatory component such as inflammatory bowel disease (IBD) or diverticular disease using budesonide MMX compositions.
    Type: Application
    Filed: August 6, 2019
    Publication date: May 28, 2020
    Applicants: COSMO TECHNOLOGIES LIMITED, SANTARUS, INC.
    Inventors: Gerald Thomas PROEHL, Wendell WIERENGA, Michael Fangching HUANG, Emerson David BALLARD, II, Luigi MORO
  • Methods for the Treatment of Abnormal Involuntary Movement Disorders
    Publication number: 20180318281
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Application
    Filed: July 19, 2018
    Publication date: November 8, 2018
    Inventors: David Stamler, Michael Fangching Huang
  • METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS
    Publication number: 20180064701
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Application
    Filed: October 2, 2017
    Publication date: March 8, 2018
    Inventors: David Stamler, Michael Fangching Huang
  • METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS
    Publication number: 20170326131
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Application
    Filed: August 2, 2017
    Publication date: November 16, 2017
    Inventors: David Stamler, Michael Fangching Huang
  • METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS
    Publication number: 20170151227
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Application
    Filed: February 9, 2017
    Publication date: June 1, 2017
    Inventors: David Stamler, Michael Fangching Huang
  • METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS
    Publication number: 20160287574
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Application
    Filed: March 7, 2016
    Publication date: October 6, 2016
    Inventors: David Stamler, Michael Fangching Huang
  • METHOD FOR TREATING INTESTINAL DISEASES PRESENTING AT LEAST ONE INFLAMMATORY COMPONENT
    Publication number: 20150017239
    Abstract: The present disclosure relates to methods for treating intestinal diseases presenting at least one inflammatory component such as inflammatory bowel disease or diverticular disease and/or maintaining remission of intestinal diseases presenting at least one inflammatory component such as inflammatory bowel disease (IBD) or diverticular disease using budesonide MMX compositions.
    Type: Application
    Filed: February 13, 2013
    Publication date: January 15, 2015
    Applicants: SANTARUS INC., COSMO TECHNOLOGIES LIMITED
    Inventors: Luigi Moro, Gerald Thomas Proehl, Wendell Wierenga, Michael Fangching Huang, Emerson David Ballard, II
  • METHOD FOR TREATING INTESTINAL DISEASES PRESENTING AT LEAST ONE INFLAMMATORY COMPONENT
    Publication number: 20140187517
    Abstract: The present disclosure relates to methods for treating intestinal diseases presenting at least one inflammatory component such as inflammatory bowel disease or diverticular disease and/or maintaining remission of intestinal diseases presenting at least one inflammatory component such as inflammatory bowel disease (IBD) or diverticular disease using budesonide MMX compositions.
    Type: Application
    Filed: March 5, 2014
    Publication date: July 3, 2014
    Applicants: SANTARUS, INC., COSMO TECHNOLOGIES LIMITED
    Inventors: Gerald Thomas PROEHL, Wendell WIERENGA, Michael Fangching HUANG, Emerson David BALLARD, II, Luigi MORO